Mitochondrial DNA 4977 bp Deletion in Peripheral Blood Is Associated With Polycystic Ovary Syndrome
BackgroundPolycystic ovary syndrome (PCOS) is a common endocrine disorder worldwide. We aimed to examine the associations of two mitochondrial DNA (mtDNA) biomarkers in the peripheral blood, mtDNA copy number (CN), and mtDNA4977 deletion rate (DR), with PCOS in a clinical setting.MethodsWe performed...
Main Authors: | Mujin Ye, Bin Hu, Weihui Shi, Fei Guo, Chenming Xu, Shuyuan Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2021.675581/full |
Similar Items
-
Analysis of the mitochondrial 4977 bp deletion in patients with hepatocellular carcinoma
by: Guo ZS, et al.
Published: (2017-06-01) -
Association of large scale 4977-bp "common" deletions in sperm mitochondrial DNA with asthenozoospermia and oligoasthenoteratozoospermia
by: Prafulla S Ambulkar, et al.
Published: (2016-01-01) -
A comprehensive overview of mitochondrial DNA 4977-bp deletion in cancer studies
by: Abdul Aziz Mohamed Yusoff, et al.
Published: (2019-04-01) -
Mitochondrial DNA Content May Not Be a Reliable Screening Biomarker for Live Birth After Single Euploid Blastocyst Transfer
by: Xuanyou Zhou, et al.
Published: (2021-11-01) -
Growth Retardation in the Course of Fanconi Syndrome Caused by the 4977-bp Mitochondrial DNA Deletion: A Case Report
by: Ting Li, et al.
Published: (2021-10-01)